Review on Dose, Destination and Delivery aspects of Methotrexate

Chakshu Walia; Naveen Sharma; Nitish Kumar; Deepali Thakur

Review on Dose, Destination and Delivery aspects of Methotrexate

Authors: Chakshu Walia, Naveen Sharma, Nitish Kumar, Deepali Thakur

Unique Paper ID: 162705
Volume: 10
Issue: 10
PageNo: 792-800

Keywords: Inflammation Methotrexate immune system Mechanism dose adverse effects.

Abstract:
Methotrexate drug belongs to the group of medicines i.e., Antineoplastics (cancer medicines). It leads in blockage of enzyme that is needed by cells to live. It is also used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma) or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. It may also be used to control juvenile rheumatoid arthritis. It is also used to reduce the activity of the immune system for people who are suffering from such problems. The immune system normally protects the body from infections by causeâ€™s inflammation to fight against them. There are several sign and symptoms of inflammation i.e., redness, swelling, heat and pain. MTX is now prescribed atleast 500,000 patients with RA worldwide, making it far the most commonly used disease modifying antirheumatic drug. It has been used to treat millions of patients with malignant and autoimmune diseases. Methotrexate has been used clinically in the treatment of malignancy, psoriasis, rheumatoid arthritis, and other autoimmune and inflammatory disorders. Methotrexate has also been used with misoprostol for voluntary abortion and in the treatment of ectopic pregnancy

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 10
Issue: 10
PageNo: 792-800

Review on Dose, Destination and Delivery aspects of Methotrexate

Available:https://ijirt.org/Article?manuscript=162705

19 Apr, 2024

Review on Chemistry, Reproduction, Sex determination, Taxonomy and Medical uses of Cannabis Sativa

28 Mar, 2024

Review on Sodium Valproate: Mechanism, Pharmacokinetics, Adverse Effects

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry